Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Rizzari

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
Pediatric Blood & Cancer|February 23, 2026
Successful Treatment of Multirefractory Immune Thrombocytopenia in Rubinstein-Taybi Syndrome With Combined Rituximab and EltrombopagDavide Colombo, Alessandra Sala, Melissa Modola, et al.
Journal of Pediatric Hematology/Oncology|March 8, 2005
Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective studyNicola Santoro, Paola Giordano, Giovanni Carlo Del Vecchio, et al.
Pediatric Blood & Cancer|October 5, 2023
Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trialsKatherine A Janeway, Luis Gros, Stefan Schwartz, et al.
Pediatric Blood & Cancer|June 27, 2023
A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trialsKatherine A Janeway, Luis Gros, Stefan Schwartz, et al.
Leukemia|May 17, 2003
Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemiaAlessandra Sala, Marina Lanciotti, Maria Grazia Valsecchi, et al.
Hemasphere|November 9, 2020
High <i>EVI1</i> Expression due to <i>NRIP1/EVI1</i> Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric CaseMariella D'Angiò, Grazia Fazio, Andrea Grioni, et al.
Cancer|September 9, 2010
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginaseRob Pieters, Stephen P Hunger, Joachim Boos, et al.
European Journal of Drug Metabolism and Pharmacokinetics|August 19, 2025
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug ExposureGudrun Würthwein, Christian Siebel, Claudia Lanvers-Kaminsky, et al.
British Journal of Haematology|July 31, 2015
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trialPaola Quarello, Franca Fagioli, Giuseppe Basso, et al.
Journal of Child Neurology|December 11, 2012
Cerebroretinal microangiopathy with calcifications and cysts associated with CTC1 and NDP mutationsRomina Romaniello, Filippo Arrigoni, Andrea Citterio, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Pediatric Blood & Cancer|February 23, 2026
Successful Treatment of Multirefractory Immune Thrombocytopenia in Rubinstein-Taybi Syndrome With Combined Rituximab and EltrombopagDavide Colombo, Alessandra Sala, Melissa Modola, et al.
Journal of Pediatric Hematology/Oncology|March 8, 2005
Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective studyNicola Santoro, Paola Giordano, Giovanni Carlo Del Vecchio, et al.
Pediatric Blood & Cancer|October 5, 2023
Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trialsKatherine A Janeway, Luis Gros, Stefan Schwartz, et al.
Pediatric Blood & Cancer|June 27, 2023
A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trialsKatherine A Janeway, Luis Gros, Stefan Schwartz, et al.
Leukemia|May 17, 2003
Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemiaAlessandra Sala, Marina Lanciotti, Maria Grazia Valsecchi, et al.
Hemasphere|November 9, 2020
High <i>EVI1</i> Expression due to <i>NRIP1/EVI1</i> Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric CaseMariella D'Angiò, Grazia Fazio, Andrea Grioni, et al.
Cancer|September 9, 2010
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginaseRob Pieters, Stephen P Hunger, Joachim Boos, et al.
European Journal of Drug Metabolism and Pharmacokinetics|August 19, 2025
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug ExposureGudrun Würthwein, Christian Siebel, Claudia Lanvers-Kaminsky, et al.
British Journal of Haematology|July 31, 2015
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trialPaola Quarello, Franca Fagioli, Giuseppe Basso, et al.
Journal of Child Neurology|December 11, 2012
Cerebroretinal microangiopathy with calcifications and cysts associated with CTC1 and NDP mutationsRomina Romaniello, Filippo Arrigoni, Andrea Citterio, et al.
Pageof 15